Innovation
The evidence shows that by controlling risk factors and taking precautions added to the rest of the population, contagion by Covid 19 can be avoided.

Evaluation System
The poster offers contact with the Cystic Fibrosis Unit or with an emergency number: 112 to ensure that the symptoms are correctly evaluated.

Assessment
COVID-19 symptoms and lung disease exacerbations may be difficult to differentiate at initial presentation. It is recommended to find more information at: Spanish Federation

References
www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Cartel_Fibrosis_Quistica.pdf" target="_blank">www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Cartel_Fibrosis_Quistica.pdf" target="_blank">www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Cartel_Fibrosis_Quistica.pdf" target="_blank">www.sanidad.gob.es/areas/alertasEmergenciasSanitarias/alertasActuales/nCov/documentos/COVID19_Cartel_Fibrosis_Quistica.pdf


Spanish Cystic Fibrosis Federation: fibrosisquistica.org" target="_blank">fibrosisquistica.org" target="_blank">fibrosisquistica.org


Spanish Cystic Fibrosis Society: www.sefq.es/" target="_blank">www.sefq.es/" target="_blank">www.sefq.es/" target="_blank">www.sefq.es/


Care Guide for Patients with Cystic Fibrosis (CF) during Covid-19: www.sefq.es/_pdfs/GuiaFQCOVID19.pdf" target="_blank">www.sefq.es/_pdfs/GuiaFQCOVID19.pdf" target="_blank">www.sefq.es/_pdfs/GuiaFQCOVID19.pdf" target="_blank">www.sefq.es/_pdfs/GuiaFQCOVID19.pdf


ECFS COVID-19 Information: ecfs.eu/covid19


WHO COVID-19 Guidance: who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance